HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Hydrocodone Bitartrate, Chlorpheniramine Maleate And Pseudoephedrine Hydrochloride patents expire, and when can generic versions of Hydrocodone Bitartrate, Chlorpheniramine Maleate And Pseudoephedrine Hydrochloride launch?
Hydrocodone Bitartrate, Chlorpheniramine Maleate And Pseudoephedrine Hydrochloride is a drug marketed by Apozeal Pharms, Mayne Pharma Inc, Padagis Us, and Tris Pharma Inc. and is included in four NDAs.
The generic ingredient in HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE is chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride profile page.
Summary for HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
US Patents and Regulatory Information for HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apozeal Pharms | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 206660-001 | May 15, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tris Pharma Inc | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 203838-001 | Nov 26, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mayne Pharma Inc | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 205657-001 | Aug 3, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Padagis Us | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 204627-001 | Apr 29, 2014 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |